Abstract
Toxicogenomics is an emerging technology that defines the use of novel genomic techniques to investigate the adverse effects of xenobiotic on gene expression. Toxicogenomics is based on the fact that most of relevant toxicological effects of a compound affect directly or indirectly the gene expression. The most common methods to profile gene expression at the transcript level are Northern Blotting and the real-time PCR. While commonly used and well accepted, these techniques are now superseded by new technologies allowing the analysis of the expression for multiple genes simultaneously. DNA microarrays are now developed for simultaneous gene analysis but inherent to such multiple assays, their quantitative aspect and their relevance for toxicogenomics have been questioned. We will review here recent studies on their use for toxicogenomics and examine the possible future of such technology in complementation with the other toxicology methods.
Keywords: low-density microarray, quantitative assay, mechanistic toxicogenomics, drug metabolism, predictive toxicogenomics, rat liver
Combinatorial Chemistry & High Throughput Screening
Title: DNA Microarrays as a Tool in Toxicogenomics
Volume: 7 Issue: 3
Author(s): F. de Longueville, V. Bertholet and J. Remacle
Affiliation:
Keywords: low-density microarray, quantitative assay, mechanistic toxicogenomics, drug metabolism, predictive toxicogenomics, rat liver
Abstract: Toxicogenomics is an emerging technology that defines the use of novel genomic techniques to investigate the adverse effects of xenobiotic on gene expression. Toxicogenomics is based on the fact that most of relevant toxicological effects of a compound affect directly or indirectly the gene expression. The most common methods to profile gene expression at the transcript level are Northern Blotting and the real-time PCR. While commonly used and well accepted, these techniques are now superseded by new technologies allowing the analysis of the expression for multiple genes simultaneously. DNA microarrays are now developed for simultaneous gene analysis but inherent to such multiple assays, their quantitative aspect and their relevance for toxicogenomics have been questioned. We will review here recent studies on their use for toxicogenomics and examine the possible future of such technology in complementation with the other toxicology methods.
Export Options
About this article
Cite this article as:
Longueville de F., Bertholet V. and Remacle J., DNA Microarrays as a Tool in Toxicogenomics, Combinatorial Chemistry & High Throughput Screening 2004; 7 (3) . https://dx.doi.org/10.2174/1386207043328841
DOI https://dx.doi.org/10.2174/1386207043328841 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mycobacterium Tuberculosis in New Biologic Era
Current Rheumatology Reviews The Gut Microbiome
Inflammation & Allergy - Drug Targets (Discontinued) Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases
Current Genomics Managing Clopidogrel Hypersensitivity without Interrupting Therapy: The Toronto Approach
Current Vascular Pharmacology Genetically-Modified Hematopoietic Stem Cells and their Progeny for Widespread and Efficient Protein Delivery to Diseased Sites: The Case of Lysosomal Storage Disorders
Current Gene Therapy Modulation of Individual Susceptibility to the No-Reflow Phenomenon after Acute Myocardial Infarction
Current Pharmaceutical Design The Role of Reactive Oxygen Species in Tumor Treatment and its Impact on Bone Marrow Hematopoiesis
Current Drug Targets Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?
Recent Patents on Anti-Cancer Drug Discovery MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
Current Cancer Drug Targets Antioxidant to Treat Osteoarthritis: Dream or Reality?
Current Drug Targets Acute <i>Versus</i> Chronic Administration of Calcineurin-Inhibitors Differentially Affect T-Cell Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Stress and the α7 Nicotinic Acetylcholine Receptor
Current Drug Targets Interlocked Systems in Nanomedicine
Current Topics in Medicinal Chemistry Simvastatin is Protective During Staphylococcus aureus Pneumonia
Current Pharmaceutical Biotechnology Stimulating Effects of H1-Antagonists
Current Pharmaceutical Design Indazole Derivatives Effective against Gastrointestinal Diseases
Current Topics in Medicinal Chemistry Patent Selections:
Recent Patents on Regenerative Medicine Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease
Current Neuropharmacology Prevention of Oxidative Stress and Diseases by Antioxidant Supplementation
Medicinal Chemistry